204 pending office actions • 140 clients
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 19374167 | Untitled | Translational And Fundamental Technologies Institute LLC | YABUT, DIANE D | 3771 | Non-Final OA | |
| 18670095 | Untitled | Legionarius, LLC | TON, MARTIN TRUYEN | 3771 | Non-Final OA | |
| 18036473 | Untitled | President and Fellows of Harvard College | TRAN, CHRISTINA L | 1637 | Non-Final OA | |
| 19117231 | SMALL-SIZE HIGH-VOLTAGE DIRECT CURRENT CONTACTOR | Kunshan Guoliyuantong New Energy Technology Co., Ltd. | HOMZA, LISA NHUNG | 2837 | Non-Final OA | Mar 31, 2025 |
| 19055839 | OPTICAL MICROSCOPY | Cambridge Enterprise Limited | COOK, JONATHON | 2877 | Non-Final OA | Feb 18, 2025 |
| 18980973 | MULTISENSOR BRACELET | Legionarius, LLC | HUNNINGS, TRAVIS R | 2689 | Non-Final OA | Dec 13, 2024 |
| 18826883 | METHODS, COMPOSITIONS AND SYSTEMS FOR SOLID-STATE BAROCALORIC APPLICATIONS | President and Fellows of Harvard College | PETTITT, JOHN F | 3763 | Final Rejection | Sep 06, 2024 |
| 18818268 | ANTIBODIES WITH FC MODIFICATIONS AND METHODS OF USING THE SAME | The General Hospital Corporation | GUSTILO, ESTELLA M | 1646 | Non-Final OA | Aug 28, 2024 |
| 18780069 | METHODS OF TREATMENT OF PRIMARY BILIARY CHOLANGITIS | Ipsen Pharma | WILSON, JERICA KATLYNN | 1621 | Non-Final OA | Jul 22, 2024 |
| 18662148 | VIRUS | Iosbio Ltd. | SHOMER, ISAAC | 1612 | Non-Final OA | May 13, 2024 |
| 18709255 | BACTERIAL STRAINS FOR TREATING DISEASE | Microba Ip Pty Ltd. | FAN, WEIHUA | 1663 | Non-Final OA | May 10, 2024 |
| 18658154 | SYSTEM FOR DETECTING MICRO-NEUROMAS AND METHODS OF USE THEREOF | President and Fellows of Harvard College | SIPES, JOHN CURTIS | 2872 | Non-Final OA | May 08, 2024 |
| 18707464 | ENGINEERED RUBISCO ENZYME COMPLEXES | Cornell University | BUI, PHUONG T | 1663 | Non-Final OA | May 03, 2024 |
| 18653106 | METHODS OF TREATING CANCER | Inspirna, Inc. | HUTTER, GILLIAN A | 1625 | Non-Final OA | May 02, 2024 |
| 18706302 | DETECTION, STAGING, MONITORING AND TREATING A DISEASE OR A CONDITION | Sunbird Bio, Inc. | BOWERS, ERIN M | 1653 | Non-Final OA | Apr 30, 2024 |
| 18704112 | METHODS OF IMPLANTING ENGINEERED TISSUE CONSTRUCTS | Satellite Biosciences, Inc. | JANOSKO, CHASITY PAIGE | 1613 | Non-Final OA | Apr 24, 2024 |
| 18635272 | SYSTEM AND PROGRAM FOR COGNITIVE SKILL TRAINING | Thynk, Inc. | LANE, DANIEL E | 3715 | Non-Final OA | Apr 15, 2024 |
| 18688518 | METHODS FOR IDENTIFYING CROSS-MODAL FEATURES FROM SPATIALLY RESOLVED DATA SETS | The General Hospital Corporation | RIVERA-MARTINEZ, GUILLERMO M | 2677 | Non-Final OA | Mar 01, 2024 |
| 18688617 | METHODS OF PRODUCING HUMAN MILK OLIGOSACCHARIDES AND COMPOSITIONS THEREOF | Amyris, Inc. | MOEHLMAN, ANDREW TERRY | 1655 | Non-Final OA | Mar 01, 2024 |
| 18681298 | LIPID-BASED COMPOSITION FOR ORAL ADMINISTRATION OF BRADYKININ B2-RECEPTOR ANTAGONISTS | Pharvaris GmbH | TCHERKASSKAYA, OLGA V | 1615 | Non-Final OA | Feb 05, 2024 |
| 18293684 | MOLECULAR GLUE AND SALL4 DEGRADER | Beth Lsrael Deaconess Medical Center, Inc. | HEES, OLIVER DRAGON | 1628 | Non-Final OA | Jan 30, 2024 |
| 18425076 | PROTEIN SECRETION INHIBITORS | Gate Bioscience, Inc. | MOU, LIYUAN | 1628 | Non-Final OA | Jan 29, 2024 |
| 18578618 | TREATMENT OF ACUTE TISSUE INJURY | Obvia Pharmaceuticals Ltd. | MOU, LIYUAN | 1628 | Non-Final OA | Jan 11, 2024 |
| 18393145 | Preparation Method and Enrichment Method for Cyanidin-3-Diglucoside-5-Glucoside | China Agricultural University | SWIFT, CANDICE LEE | 1657 | Final Rejection | Dec 21, 2023 |
| 18540119 | USE OF ATR INHIBITORS IN COMBINATION WITH PARP INHIBITORS FOR TREATING CANCER | Repare Therapeutics Inc. | ENGLISH, CONNOR KENNEDY | 1625 | Non-Final OA | Dec 14, 2023 |
| 18537061 | USE OF ATR INHIBITORS IN COMBINATION WITH PARP INHIBITORS | Repare Therapeutics Inc. | DAVIS, BRIAN J | 1614 | Non-Final OA | Dec 12, 2023 |
| 18568440 | SUBCUTANEOUS FORMULATION AND METHODS FOR TREATING EDEMA REFRACTORY TO ORAL DIURETICS | Resq Pharmaceuticals LLC | SAEED, ALI S | 1616 | Non-Final OA | Dec 08, 2023 |
| 18568668 | DETECTING A DINUCLEOTIDE SEQUENCE IN A TARGET POLYNUCLEOTIDE | UTI LIMITED PARTNERSHIP | DAUNER, JOSEPH G | 1682 | Non-Final OA | Dec 08, 2023 |
| 35519637 | Inhaler | Neutec Inhaler Ilac Sanayi Ve Ticaret Anonim Sirketi | HOFFMAN, MICHAEL SCOTT | 2943 | Final Rejection | Dec 06, 2023 |
| 18566881 | METHODS OF PURIFYING CANNABINOIDS | Amyris, Inc. | SAIDHA, TEKCHAND | 1652 | Non-Final OA | Dec 04, 2023 |
| 18566902 | METHODS OF PURIFYING CANNABINOIDS | Amyris, Inc. | EIX, EMILY FAY | 1653 | Non-Final OA | Dec 04, 2023 |
| 18566492 | CRYSTALLINE FORMS, COMPOSITIONS CONTAINING SAME, AND METHODS OF THEIR USE | Repare Therapeutics Inc. | RAMOS LEWIS, JOSMALEN MILAGROS | 1621 | Non-Final OA | Dec 01, 2023 |
| 18564436 | IMPACT CUSHIONING MATERIAL FOR PADDED GLOVES USED IN CONTACT SPORTS | Hayabusa Fightwear Inc. | MARIN, DAKOTA | 3732 | Non-Final OA | Nov 27, 2023 |
| 18563504 | REACTOR PLANT AND METHOD TO CONTROL PERFORMANCE | Electrochaea GmbH | HOBBS, MICHAEL L | 1799 | Final Rejection | Nov 22, 2023 |
| 18516366 | PROTEIN PROSTHESES FOR MITOCHONDRIAL DISEASES OR CONDITIONS | The General Hospital Corporation | WEHBE, ANNE MARIE SABRINA | 1634 | Non-Final OA | Nov 21, 2023 |
| 18289921 | METHODS AND COMPOSITIONS FOR TREATING EPILEPSY | UNIVERSITE D'AIX-MARSEILLE | ZAHORIK, AMANDA MARY | 1636 | Final Rejection | Nov 08, 2023 |
| 18289037 | ACTIVIN RECEPTOR TYPE II CHIMERAS AND METHODS OF USE THEREOF | Keros Therapeutics, Inc. | MARTINEZ, TARA L | 1654 | Non-Final OA | Oct 31, 2023 |
| 18288870 | KETAMINE AND CANNABIS FOR THE TREATMENT OF EMOTIONAL DISORDERS | Progressive Therapeutics Inc. | MELLER, MICHAEL V | 1655 | Non-Final OA | Oct 30, 2023 |
| 18012400 | CULTURE OF ORGANOIDS | Genome Research Limited | PAULUS, ERIN VIRGINIA | 1631 | Non-Final OA | Oct 27, 2023 |
| 18287963 | TISSUE-TARGETED MODIFIED AAV CAPSIDS AND METHODS OF USE THEREOF | Astellas Gene Therapies, Inc. | PENNINGTON, HALLIE NICOLE | 1671 | Non-Final OA | Oct 23, 2023 |
| 18487666 | FORMULATIONS OF GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES | Zealand Pharma A/S | BEANE, RANDALL L | 1654 | Final Rejection | Oct 16, 2023 |
| 18379970 | APPARATUS AND METHOD FOR PRODUCING THREE-DIMENSIONAL OBJECTS | Q.Big 3D GmbH | TAUFIQ, FARAH N | 1754 | Non-Final OA | Oct 13, 2023 |
| 18377588 | COMPOSITIONS AND METHODS FOR SMALL MOLECULE BASED EXPANSION OF PLURIPOTENT STEM CELLS | Trailhead Biosystems Inc. | JACKSON III, WALTER | 1638 | Non-Final OA | Oct 06, 2023 |
| 18285560 | METHODS AND COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS | Spirovant Sciences, Inc. | BURKHART, MICHAEL D | 1638 | Non-Final OA | Oct 04, 2023 |
| 18285422 | LIGNIN-BASED COMPOSITIONS AND RELATED HYDROCARBON SEPARATION METHODS | Lignosol Ip Limited | RUNYAN, SILVANA C | 3674 | Non-Final OA | Oct 03, 2023 |
| 18284951 | COMBINATION THERAPY FOR COVID-19 VACCINATION | Dompe' Farmaceutici Spa | ALAM, DANYAL HASSAN | 1672 | Non-Final OA | Sep 29, 2023 |
| 18371694 | APPARATUS AND METHOD FOR INDUCING HUMAN OOCYTE MATURATION IN VITRO | Gameto, Inc. | CORDAS, EMILY ANN | 1632 | Final Rejection | Sep 22, 2023 |
| 18283671 | MICROGLIAL GENE SILENCING USING DOUBLE-STRANDED SIRNA | Atalanta Therapeutics, Inc. | MEYERING, SHABANA SHABBEER | 1635 | Non-Final OA | Sep 22, 2023 |
| 18281346 | COMPOSITIONS AND METHODS FOR TREATING X-LINKED MYOTUBULAR MYOPATHY | Audentes Therapeutics, Inc. | DITMER, KATHRYN ELIZABETH | 3785 | Non-Final OA | Sep 11, 2023 |
| 18244773 | GONADOTROPIN-RELEASING HORMONE ANTAGONIST DOSING REGIMENS FOR TREATING UTERINE FIBROIDS AND REDUCING MENSTRUAL BLOOD LOSS | Kissei Pharmaceutical Co., Ltd. | COPPINS, JANET L | 1628 | Final Rejection | Sep 11, 2023 |
| 18280325 | TREATMENT OF CORONAVIRUS INFECTIONS USING SAM CYCLE INHIBITORS | Technische Universität München | NEAGU, IRINA | 1629 | Non-Final OA | Sep 05, 2023 |
| 18279708 | CXCL8 INHIBITOR AND PHARMACEUTICAL COMPOSITION THEREOF FOR USE IN THE TREATMENT OF SEIZURES | Dompe' Farmaceutici Spa | DAHLIN, HEATHER RAQUEL | 1629 | Non-Final OA | Aug 31, 2023 |
| 18279517 | THE USE OF EMPAGLIFLOZIN FOR THE TREATMENT OF ULCERATIVE COLITIS AND CROHN'S DISEASE | The Governors of the University of Alberta | SCHACHERMEYER, SAMANTHA LYNN | 1693 | Non-Final OA | Aug 30, 2023 |
| 18277858 | METHODS FOR TREATING SENSORINEURAL HEARING LOSS USING OTOFERLIN DUAL VECTOR SYSTEMS | Decibel Therapeutics, Inc. | SHEN, WU CHENG WINSTON | 1682 | Non-Final OA | Aug 18, 2023 |
| 18276943 | METHODS AND COMPOSITIONS FOR MODULATING FGF ACTIVITY | Recovery Therapeutics, Inc. | CHONG, YONG SOO | 1623 | Non-Final OA | Aug 11, 2023 |
| 18277023 | GENE THERAPY FOR DOPAMINE TRANSPORTER DEFICIENCY SYNDROME | UCL Business Ltd | TRAN, CHRISTINA L | 1637 | Non-Final OA | Aug 11, 2023 |
| 18276709 | PHARMACEUTICALLY ACCEPTABLE SALTS OF PSILOCIN AND USES THEREOF | Eleusis Therapeutics US, Inc. | JACKSON, SHAWQUIA | 1626 | Non-Final OA | Aug 10, 2023 |
| 18275849 | NGF ISOFORM FOR USE IN THE TREATMENT OF OCULAR PATHOLOGIES | Dompe' Farmaceutici Spa | FORD, VANESSA L | 1674 | Non-Final OA | Aug 04, 2023 |
| 18228818 | COMPOSITE EMBOLIZATION BEADS | Translational And Fundamental Technologies Institute LLC | TRAN, LARA LINH | 3791 | Non-Final OA | Aug 01, 2023 |
| 17625380 | MAGEA10 SPECIFIC T CELL RECEPTORS AND THEIR USE | Medigene Immunotherapies GmbH | ALLEN, MARIANNE P | 1647 | Non-Final OA | Jul 27, 2023 |
| 18034254 | OCULAR-TENSION-INCREASING AGENT CAPABLE OF BEING DEPRIVED OF DRUG ACTIVITY BY TEMPERATURE CONTROL | Tohoku University | SONG, JIANFENG | 1613 | Non-Final OA | Jul 21, 2023 |
| 18224687 | IMPLANT FOR OVARIAN DECLINE AND METHODS OF MANUFACTURING AN IMPLANT FOR OVARIAN DECLINE | Gameto, Inc. | AZPURU, CARLOS A | 1617 | Final Rejection | Jul 21, 2023 |
| 18273395 | ANTAGONISTIC ANTI-TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY ANTIBODIES | The General Hospital Corporation | LEE, YIE CHIA | 1642 | Non-Final OA | Jul 20, 2023 |
| 18224138 | EARLY ADMINISTRATION OF LOW-DOSE COLCHICINE AFTER MYOCARDIAL INFARCTION | Institut De Cardiologie De Montreal | DAVIS, BRIAN J | 1614 | Final Rejection | Jul 20, 2023 |
| 18273121 | METHODS OF MITIGATING MYOCARDIAL DAMAGE DUE TO EXTRACORPOREAL MEMBRANE OXYGENATION | Tufts Medical Center, Inc. | WEHRHEIM, LINDSEY GAIL | 3799 | Non-Final OA | Jul 19, 2023 |
| 18272168 | CD64 CHIMERIC RECEPTOR AND USES THEREOF | CONSIGLIO NAZIONALE DELLE RICERCHE | DRISCOLL, LORA E BARNHART | 3991 | Non-Final OA | Jul 13, 2023 |
| 18347185 | METHOD FOR IDENTIFYING SUBGROUPS OF CIRCULATING TUMOR CELLS (CTCS) IN THE CTC POPULATION OF A BIOLOGICAL SAMPLE | Unknown | WOOLWINE, SAMUEL C | 1681 | Non-Final OA | Jul 05, 2023 |
| 18268139 | USE OF GLP-2 ANALOGUES IN PATIENTS WITH RENAL INSUFFICIENCY | Zealand Pharma A/S | BOWLES, DAVID PAUL | 1654 | Non-Final OA | Jun 21, 2023 |
| 17910686 | GENE THERAPY OF NIEMANN-PICK DISEASE TYPE C | UCL Business Ltd | ABBOTT, KODYE LEE | 1634 | Non-Final OA | Jun 16, 2023 |
| 18267327 | TREATMENT OF CANCER ASSOCIATED WITH DYSREGULATED NOVEL OPEN READING FRAME PRODUCTS | International Centre For Genetic Engineering And Biotechnology | JOHANSEN, PETER N. | 1644 | Non-Final OA | Jun 14, 2023 |
| 18267355 | VACCINE COMPOSITION FOR NOVEL CORONAVIRUS INFECTION | Institute Of Biophysics, Chinese Academy Of Sciences | LI, BAO Q | 1671 | Non-Final OA | Jun 14, 2023 |
| 18267230 | METHOD FOR MASS PRODUCTION OF HIGHLY PURE, STEM CELL-DERIVED EXTRACELLULAR VESICLE BY USING PEPTIDE | Konkuk University Industrial Cooperation Corp. | NGUYEN, NGHI V | 1653 | Non-Final OA | Jun 14, 2023 |
| 18266387 | TREATMENT OF DISEASES ASSOCIATED WITH VARIANT NOVEL OPEN READING FRAMES | International Centre For Genetic Engineering And Biotechnology | ZAHORIK, AMANDA MARY | 1636 | Non-Final OA | Jun 09, 2023 |
| 18256304 | METHOD OF TREATING HEREDITARY HEMORRHAGIC TELANGIECTASIA USING PAZOPANIB | Hht Foundation International, Inc. | WORSHAM, JESSICA N | 1615 | Final Rejection | Jun 07, 2023 |
| 18039846 | OLIGONUCLEOTIDES | Oxford University Innovation Limited | OLSON, ALEXANDRA NADINE | 1684 | Non-Final OA | Jun 01, 2023 |
| 18039813 | RNA-TARGETING COMPOSITIONS AND METHODS FOR TREATING CAG REPEAT DISEASES | Astellas Gene Therapies, Inc. | ZARA, JANE J | 1637 | Non-Final OA | Jun 01, 2023 |
| 18039812 | RNA-TARGETING COMPOSITIONS AND METHODS FOR TREATING MYOTONIC DYSTROPHY TYPE 1 | Astellas Gene Therapies, Inc. | VIJAYARAGHAVAN, JAGAMYA NMN | 1633 | Non-Final OA | Jun 01, 2023 |
| 18204342 | METHODS OF VAPOR DEPOSITION OF METAL HALIDES | Trustees Of Tufts College | PENNY, TABATHA L | 1712 | Non-Final OA | May 31, 2023 |
| 18326661 | SEGMENTED GASTROINTESTINAL DEVICES AND METHODS OF USE THEREOF | Morphic Medical, Inc. | YANG, CHENG FONG | 3781 | Final Rejection | May 31, 2023 |
| 18201498 | PREFERRED ORAL TESTOSTERONE UNDECANOATE THERAPY TO ACHIEVE TESTOSTERONE REPLACEMENT TREATMENT | Marius Pharmaceuticals, Inc. | MOU, LIYUAN | 1628 | Non-Final OA | May 24, 2023 |
| 18199415 | METHODS AND COMPOSITIONS FOR GENERATING HUMAN MIDBRAIN DOPAMINERGIC NEURONS FROM NEURAL PROGENITOR CELLS | Trailhead Biosystems Inc. | STAVROU, CONSTANTINA E | 1632 | Non-Final OA | May 19, 2023 |
| 18037597 | COMPUTER PROGRAM FOR TRAINING A NEUROLOGICAL CONDITION DETECTION ALGORITHM, METHOD OF PROGRAMMING AN IMPLANTABLE NEUROSTIMULATION DEVICE AND COMPUTER PROGRAM THEREFOR | Precisis GmbH | SCHLUETER, MARY GRACE | 3796 | Final Rejection | May 18, 2023 |
| 18037196 | CYCLOTRON TARGET AND LANTHANUM THERANOSTIC PAIR FOR NUCLEAR MEDICINE | The Governors of the University of Alberta | DAVIS, SHARON M | 3646 | Non-Final OA | May 16, 2023 |
| 18037030 | COMPOSITIONS AND METHODS FOR TREATING POMPE DISEASE | AvroBio, Inc. | BRISTOL, LYNN ANNE | 1643 | Non-Final OA | May 15, 2023 |
| 18037007 | COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF PRETERM LABOR | Xoma (Us) LLC | HUI, SAN MING R | 1627 | Non-Final OA | May 15, 2023 |
| 18196538 | MIR-375- AND MIR-1-REGULATED COXSACKIEVIRUS B3 HAS NO PANCREAS AND HEART TOXICITY BUT STRONG ANTITUMOR EFFICIENCY IN COLORECTAL CARCINOMAS | Technische Universität Berlin | SPENCE, JENNIFER SUZANNE | 1633 | Non-Final OA | May 12, 2023 |
| 18036720 | METHODS FOR PURIFYING INTER-ALPHA INHIBITOR PROTEINS | Prothera Biologics, Inc. | WALLENHORST, MAUREEN | 1797 | Non-Final OA | May 12, 2023 |
| 18314339 | ANTI-TL1A ANTIBODIES AND METHODS OF USE THEREOF | Bristol-Myers Squibb Company | SUNSHINE, HANNAH LOUISE | 1647 | Non-Final OA | May 09, 2023 |
| 18035640 | POLYSACCHARIDES FOR USE IN TREATING SARS-COV-2 INFECTIONS | Ndpd Pharma, Inc. | ANTHOPOLOS, PETER | 1611 | Non-Final OA | May 05, 2023 |
| 18035582 | POLYSACCHARIDES FOR IV ADMINISTRATION THAT TREAT SARS-COV-2 INFECTIONS | Pharmalectin, Inc. | CHO, DAVID H | 1693 | Non-Final OA | May 05, 2023 |
| 18140302 | QUINAZOLINONES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME | Repare Therapeutics Inc. | STOCKTON, LAURA LYNNE | 1626 | Non-Final OA | Apr 27, 2023 |
| 18140188 | METABOLIC BIOMARKERS OF INFLAMMATORY BOWEL DISEASE | Institut De Cardiologie De Montreal | BOWERS, ERIN M | 1653 | Final Rejection | Apr 27, 2023 |
| 18135460 | IL-8 INHIBITORS FOR USE IN THE TREATMENT OF SOME SARCOMAS | Research Institute AT Nationwide Children'S Hospital | LEE, WILLIAM Y | 1623 | Non-Final OA | Apr 17, 2023 |
| 18299877 | PHARMACEUTICAL COMPOSITIONS OF ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES AND METHODS OF USE | Hoffmann-La Roche, Inc. | TRAN HO, LAM THUY VI | 1647 | Non-Final OA | Apr 13, 2023 |
| 18031772 | USE OF N-MYRISTOYL TRANSFERASE (NMT) INHIBITORS IN THE TREATMENT OF CANCER, AUTOIMMUNE DISORDERS, AND INFLAMMATORY DISORDERS | Pacylex Pharmaceuticals Inc. | VALENROD, YEVGENY | 1628 | Final Rejection | Apr 13, 2023 |
| 18133900 | DEVICE AND METHOD FOR OBTAINING IMMUNO-STIMULATORY ANTIGEN-PRESENTING CELLS | Yale University | JUEDES, AMY E | 1644 | Non-Final OA | Apr 12, 2023 |
| 18030858 | POLAR LIQUIDS WITH HIGH POROSITY AND USES THEREOF | President and Fellows of Harvard College | SMARI, ABDUL-RAHMAN YUSUF WALEED | 1736 | Non-Final OA | Apr 07, 2023 |
| 18030876 | PEPTIDE INHIBITORS OF GLIOMA-ASSOCIATED ONCOGENE DERIVED FROM THE COILED-COIL DIMERIZATION DOMAIN OF Kif7 | The General Hospital Corporation | REYNOLDS, FRED H | 1658 | Non-Final OA | Apr 07, 2023 |
| 18030627 | SUBJECT-SPECIFIC TREATMENTS FOR VENETOCLAX-RESISTANT ACUTE MYELOID LEUKEMIA | The Regents of the University of Colorado | SALMON, KATHERINE D | 1682 | Non-Final OA | Apr 06, 2023 |
| 18030439 | CANNABINOID-CONTAINING COMPOSITIONS AND USE FOR TREATING AND PREVENTING DISEASES | Max Biology Co. Ltd. | BASQUILL, SEAN M | 1614 | Final Rejection | Apr 05, 2023 |
| 18028662 | ELECTRONIC WASTE COMPOSITE ARTICLE OR MATERIAL AND PROCESS FOR MAKING SAME | Excir Works Corp. | PIRO, NICHOLAS ANTHONY | 1738 | Non-Final OA | Mar 27, 2023 |
| 18028002 | MAGE-A3 SPECIFIC T CELL RECEPTORS AND THEIR USE | Medigene Immunotherapies GmbH | SWARTWOUT, BRIANNA KENDALL | 1644 | Non-Final OA | Mar 23, 2023 |
| 18028025 | PRAME SPECIFIC T-CELL RECEPTORS AND USES THEREOF | Medigene Immunotherapies GmbH | BUTTICE, AUDREY L | 1647 | Non-Final OA | Mar 23, 2023 |
| 18026921 | METHOD FOR EXTRACTION OF COINAGE METALS | Excir Works Corp. | CARDA, DANIELLE MARIE | 1738 | Non-Final OA | Mar 17, 2023 |
| 18044747 | RIBITOL TREATMENT | The Charlotte Mecklenburg Hospital Authority D/B/A Atrium Health | NEAGU, IRINA | 1629 | Non-Final OA | Mar 09, 2023 |
| 18025459 | DEVICES AND METHODS FOR CONTINUOUS EXTRUSION OF A DRUG INTO THE MOUTH | SynAgile Corporation | WILLIAMS, CATHERINE SERKE | 3993 | Non-Final OA | Mar 09, 2023 |
| 17924496 | COMBINATION THERAPY FOR TTR AMYLOIDOSIS | Neurimmune AG | HOWARD, ZACHARY C | 1674 | Non-Final OA | Mar 06, 2023 |
| 18024624 | PEPTIDES ENDOWED WITH ANGIOGENIC ACTIVITY | Dompe' Farmaceutici Spa | FISHER, MELISSA L | 1658 | Non-Final OA | Mar 03, 2023 |
| 18024179 | METHODS FOR IDENTIFYING CROSS-MODAL FEATURES FROM SPATIALLY RESOLVED DATA SETS | The General Hospital Corporation | TRAN, DUY ANH | 2674 | Non-Final OA | Mar 01, 2023 |
| 18021912 | CONFORMATION-SPECIFIC ANTIBODIES THAT BIND TAU PROTEIN AND USES THEREOF | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | WEN, SHARON X | 1641 | Non-Final OA | Feb 17, 2023 |
| 18021979 | PEPTIDE FOR THERAPEUTIC APPLICATIONS IN THE DERMATOLOGICAL FIELD | Dompe' Farmaceutici S.p.A. | DONOGHUE, BRITTNEY ERIN | 1675 | Non-Final OA | Feb 17, 2023 |
| 18021364 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING HEREDITARY ANGIOEDEMA | Orchard Therapeutics (Europe) Limited | MCCORMICK, CATHERINE LYNN | 1638 | Non-Final OA | Feb 14, 2023 |
| 18020342 | COMPOSITIONS AND METHODS FOR DECREASING INFLAMMATION | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | REDDIG, PETER J | 1646 | Final Rejection | Feb 08, 2023 |
| 18165613 | CELL MEMBRANE PENETRATING CONJUGATES | Cygenica Limited | VARADARAJ, ARCHANA | 1658 | Non-Final OA | Feb 07, 2023 |
| 18019855 | METHODS FOR THE SYNTHESIS OF PROTEIN-DRUG CONJUGATES | Cidara Therapeutics, Inc. | PATEL, SAGAR S | 1626 | Non-Final OA | Feb 06, 2023 |
| 18164151 | OLIGONUCLEOTIDE TREATMENT OF HEPATITIS B PATIENTS | Dicerna Pharmaceuticals, Inc. | ARIETI, RUTH SOPHIA | 1635 | Final Rejection | Feb 03, 2023 |
| 18163810 | OBINUTUZUMAB TREATMENT OF A DLBCL PATIENT SUBGROUP | Bruker Spatial Biology, Inc. | LU, CHENG | 1642 | Non-Final OA | Feb 02, 2023 |
| 18157453 | TREATMENT OF PELVIC ORGAN PROLAPSE | Remendium Labs LLC | KREMER, MATTHEW | 3791 | Final Rejection | Jan 20, 2023 |
| 18016490 | INHIBITORS OF COMPLEMENT FACTOR C3 AND THEIR MEDICAL USES | Zp Spv 3 K/S | DABKOWSKI, ERINNE R | 1654 | Non-Final OA | Jan 17, 2023 |
| 18154241 | METHODS AND COMPOSITIONS FOR TREATING EPILEPSY | Uniqure France | CHONG, KIMBERLY | 1636 | Non-Final OA | Jan 13, 2023 |
| 18016279 | ANTI-CLDN-18.2 ANTIBODY AND USE THEREOF | Suzhou Junmeng Biosciences Co., Ltd. | STONEBRAKER, ALYSSA RAE | 1642 | Non-Final OA | Jan 13, 2023 |
| 18014881 | VACCINE ADJUVANTS AND METHODS OF SYNTHESIZING AND USING THE SAME | Amyris, Inc. | CHAO, ALLEN | 1622 | Non-Final OA | Jan 06, 2023 |
| 18014561 | COMPOSITIONS AND METHODS FOR TARGETING TUMOR ASSOCIATED TRANSCRIPTION FACTORS | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | GOMEZ RODRIGUEZ, JULIO WASHINGTON | 1637 | Non-Final OA | Jan 05, 2023 |
| 18014701 | INTERFEROMETRIC SCATTERING CORRELATION (ISCORR) MICROSCOPY | Cambridge Enterprise Limited | AMARA, MOHAMED K | 2877 | Final Rejection | Jan 05, 2023 |
| 17791756 | ARTIFICIAL EXCITATORY SYNAPSE CONNECTOR AND USE THEREOF FOR SPINAL CORD INJURY | Fujita Academy | WANG, CHANG YU | 1675 | Non-Final OA | Dec 22, 2022 |
| 18002368 | METHOD OF TREATMENT OF INFLAMMATORY BOWEL DISEASE USING ANTI-TL1A ANTIBODIES | Pfizer, Inc. | KAUFMAN, CLAIRE M | 1674 | Non-Final OA | Dec 19, 2022 |
| 18067247 | AORTA-SPECIFIC DNA METHYLATION PATTERNS IN CELL-FREE DNA FROM PATIENTS WITH BICUSPID AORTIC VALVE-ASSOCIATED AORTOPATHY | UTI LIMITED PARTNERSHIP | YU, TIAN NMN | 1681 | Non-Final OA | Dec 16, 2022 |
| 18010513 | MATURED THREE-DIMENSIONAL PRINTED COMPOSITIONS AND USES THEREOF | Auregen Biotherapeutics SA | SCHUBERG, LAURA J | 1631 | Non-Final OA | Dec 15, 2022 |
| 18009495 | NEW DRUG DELIVERY SYSTEM FOR OPHTHALMIC USE | Dompe' Farmaceutici S.p.A. | OLSEN, KAELEIGH ELIZABETH | 1619 | Final Rejection | Dec 09, 2022 |
| 18061755 | COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN CANINES AND METHODS OF USE | Invetx, Inc. | DAHLE, CHUN WU | 1641 | Non-Final OA | Dec 05, 2022 |
| 18060901 | METHODS AND SYSTEMS FOR DETERMINING PHYSICAL PROBABILITIES OF PARTICLES | President and Fellows of Harvard College | HOOVER, BRENT JOHNSTON | 2127 | Non-Final OA | Dec 01, 2022 |
| 18071388 | METHODS AND COMPOSITIONS FOR MAINTAINING AND EXPANDING HEMATOPOIETIC STEM CELLS | Trailhead Biosystems Inc. | TAKENAKA, RISA | 1632 | Non-Final OA | Nov 29, 2022 |
| 17926106 | IMMUNE CELLS WITH ENHANCED FUNCTION | The Queensland Institute of Medical Research | VAN BUREN, LAUREN K | 1638 | Non-Final OA | Nov 17, 2022 |
| 17924425 | POLYNUCLEOTIDE ARRAYS | Oxford University Innovation Limited | ZHANG, KAIJIANG | 1684 | Non-Final OA | Nov 10, 2022 |
| 17924455 | AGONISTIC TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY POLYPEPTIDES | The General Hospital Corporation | WANG, CHANG YU | 1675 | Final Rejection | Nov 10, 2022 |
| 18054085 | METHODS OF SELECTING A PATIENT FOR TREATMENT OF A MAGE-A1 POSITIVE SOLID TUMOR, OF PREDICTING WHETHER A PATIENT BEING DIAGNOSED WITH MAGE-A1 POSITIVE SOLID TUMOR WILL BE RESPONSIVE TO TREATMENT OF THIS TUMOR AND OF TREATING A PATIENT BEING DIAGNOSED WITH SUCH A MAGE-A1 POSITIVE SOLID TUMOR AS WELL AS CORRESPONDING PHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC KITS | T-Knife GmbH | VAN BUREN, LAUREN K | 1638 | Non-Final OA | Nov 09, 2022 |
| 18049514 | NMR METHODS AND SYSTEMS FOR THE RAPID DETECTION OF BACTERIA | T2 Biosystems, Inc. | GIAMMONA, FRANCESCA FILIPPA | 1681 | Non-Final OA | Oct 25, 2022 |
| 17919144 | B CELL IMMUNOMODULATORY THERAPY FOR ACUTE RESPIRATORY DISTRESS SYNDROME | Holy Cross Hospital, Inc. | TIWARI, VYOMA SHUBHAM | 1634 | Final Rejection | Oct 14, 2022 |
| 17957780 | ENVIRONMENT FRIENDLY COLD RAMMING MIXTURE | Hindalco Industries Limited | KOLB, KATARZYNA I | 1767 | Non-Final OA | Sep 30, 2022 |
| 17916224 | CD3-FUSION PROTEIN AND USES THEREOF | Medigene Immunotherapies GmbH | DUFFY, BRADLEY | 1643 | Non-Final OA | Sep 30, 2022 |
| 17939198 | THERAPEUTIC AGENT FOR KERATOCONJUNCTIVE DISORDERS | Yamaguchi University | CHANDRAKUMAR, NIZAL S | 1625 | Final Rejection | Sep 07, 2022 |
| 17909696 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF INTRACELLULAR BACTERIAL INFECTIONS | Endolytix Technology, Inc. | KAMM, JUDITH MARIE | 1611 | Final Rejection | Sep 06, 2022 |
| 17905081 | PHARMACEUTICAL COMPOSITIONS OF A THERAPEUTIC POLYENE MACROLIDE AND METHODS OF THEIR USE | Biosergen AS | GALSTER, SAMUEL LEONARD | 1693 | Non-Final OA | Aug 26, 2022 |
| 17896781 | Methods and Compositions for Generating Human Forebrain Neural Progenitor Cells and for Maturation Thereof to Parvalbumin+ Interneurons | Trailhead Biosystems Inc. | SPENCER, ANDREA LYNNE MORRIS | 1631 | Non-Final OA | Aug 26, 2022 |
| 17800639 | CXCL8 (INTERLEUKIN-8) ACTIVITY INHIBITOR AND CORTICOSTEROID COMBINATION AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | Dompe' Farmaceutici Spa | LEE, ANDREW P | 1691 | Final Rejection | Aug 18, 2022 |
| 17819591 | PREPARATION AND COMPOSITION OF INTER-ALPHA INHIBITOR PROTEINS FROM HUMAN PLASMA FOR THERAPEUTIC USE | Prothera Biologics, Inc. | ORWIG, KEVIN S | 3991 | Final Rejection | Aug 12, 2022 |
| 17798344 | ACTIVATION OF NEUROPEPTIDE RECEPTORS ON PLASMACYTOID DENDRITIC CELLS TO TREAT OR PREVENT OCULAR DISEASES ASSOCIATED WITH NEOVASCULARIZATION AND INFLAMMATION | Trustees Of Tufts College | HUANG, GIGI GEORGIANA | 1613 | Non-Final OA | Aug 09, 2022 |
| 17797473 | METHODS AND COMPOSITIONS FOR PRODUCTION OF SALINE TOLERANT PLANTS | Luke Young | KUMAR, VINOD | 1663 | Final Rejection | Aug 04, 2022 |
| 17794001 | PEPTIDE INHIBITORS OF GUANINE NUCLEOTIDE EXCHANGE FACTOR H-1 | UCL Business Ltd | KOMATSU, LI N | 1658 | Non-Final OA | Jul 20, 2022 |
| 17810197 | METHODS FOR SELECTIVE LEACHING AND EXTRACTION OF PRECIOUS METALS IN ORGANIC SOLVENTS | Excir Works Corp. | BAUM, ZACHARY JOHN | 1736 | Final Rejection | Jun 30, 2022 |
| 17810022 | METHODS FOR THE TREATMENT OF EPILEPSY | Centre National De La Recherche Scientifique | MEYERING, SHABANA SHABBEER | 1635 | Non-Final OA | Jun 30, 2022 |
| 17610243 | ANTITUMOR AGENT AND COMPOUNDING AGENT | Keio University | ADLAM, CHANTAL PETA-GAYE | 1622 | Non-Final OA | Jun 24, 2022 |
| 17786360 | PREPARATION OF HALOGENATED ALKOXYETHANE | Commonwealth Scientific And Industrial Research Organisation | BAHTA, MEDHANIT W | 1692 | Non-Final OA | Jun 16, 2022 |
| 17834062 | ACYLATED GLP-1/GLP-2 DUAL AGONISTS | Zealand Pharma A/S | KOMATSU, LI N | 1658 | Final Rejection | Jun 07, 2022 |
| 17831012 | COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF BABESIOSIS | Tufts Medical Center, Inc. | JACKSON-TONGUE, LAKIA J | 1645 | Final Rejection | Jun 02, 2022 |
| 17825751 | ADHESIVE DEVICES AND USES THEREOF | Cohesys Inc. | BOLES, SAMEH RAAFAT | 3775 | Non-Final OA | May 26, 2022 |
| 17779633 | COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF BABESIOSIS | Tufts Medical Center, Inc. | LYONS, MARY M | 1645 | Non-Final OA | May 25, 2022 |
| 17748323 | METHODS AND COMPOSITIONS FOR GENERATING HUMAN MIDBRAIN NEURAL PROGENITOR CELLS | Trailhead Biosystems Inc. | TRAN, KHOA NHAT | 1632 | Final Rejection | May 19, 2022 |
| 17742847 | OCULAR DEVICE DELIVERY METHODS AND SYSTEMS | Layerbio, Inc. | PIPIC, ALMA | 1617 | Final Rejection | May 12, 2022 |
| 17775665 | A CORPOREAL COMPRESSION SYSTEM | Coco Industries Pty Ltd. | MOON, MATTHEW RYAN | 3785 | Non-Final OA | May 10, 2022 |
| 17735326 | COCHLEAR OUTER HAIR CELL PROMOTERS AND USES THEREOF | Decibel Therapeutics, Inc. | VIJAYARAGHAVAN, JAGAMYA NMN | 1633 | Final Rejection | May 03, 2022 |
| 17731112 | METHODS FOR ELECTRO-MECHANICAL TRANSFECTION | Kytopen Corporation | NOBLE, MARCIA STEPHENS | 1632 | Non-Final OA | Apr 27, 2022 |
| 17771627 | COMPOSITIONS AND METHODS FOR TREATING GLYCOGEN STORAGE DISORDERS | Astellas Gene Therapies, Inc. | NOBLE, MARCIA STEPHENS | 1632 | Final Rejection | Apr 25, 2022 |
| 17771375 | ADOPTIVE IMMUNOTHERAPY | The Queensland Institute of Medical Research | GILL, RACHEL B | 1671 | Final Rejection | Apr 22, 2022 |
| 17725271 | BIOREDUCTIVELY-ACTIVATED COMPOUNDS, THEIR PRODRUGS, RADIOPHARMACEUTICALS, THE COMPOSITIONS, AND THEIR APPLICATIONS IN MULTIMODAL THERANOSTIC MANAGEMENT OF HYPOXIA DISEASES INCLUDING CANCER | The Governors of the University of Alberta | DONOHUE, SEAN R | 1618 | Final Rejection | Apr 20, 2022 |
| 17715724 | EXTENDED-RELEASE INJECTABLE GEL FORMULATIONS CONTAINING ANGIOTENSIN-(1-7) OLIGOPEPTIDES OR VARIANTS THEREOF | Proneurogen, Inc. | PEEBLES, KATHERINE | 1617 | Final Rejection | Apr 07, 2022 |
| 17766646 | HELPER PLASMID-BASED GUTLESS ADENOVIRUS PRODUCTION SYSTEM | Genenmed Co., Ltd. | SHIBUYA, MARK LANCE | 1631 | Final Rejection | Apr 05, 2022 |
| 17766280 | INHIBITOR OF CELL PROLIFERATION IN OBINUTUZUMAB RESISTANT CD20-POSITIVE CANCER, AND MEDICINAL COMPOSITION, MEDICINE, PRODUCTION, METHOD FOR INHIBITING CELL PROLIFERATION, THERAPEUTIC METHOD, TYPE II ANTI-CD20 ANTIBODY, COMPOUNDS, COMBINATION OF SAME, ENHANCER AND INDUCER, EACH RELATING THERETO | Chugai Seiyaku Kabushiki Kaisha | SANG, HONG | 1646 | Non-Final OA | Apr 04, 2022 |
| 17709710 | TOPICAL FORMULATIONS OF 5-ALPHA-REDUCTASE INHIBITORS AND USES THEREOF | Varsona Therapeutics, Inc. | DRAPER, LESLIE A ROYDS | 1629 | Non-Final OA | Mar 31, 2022 |
| 17641904 | METHODS OF TREATING CANCER | Inspirna, Inc. | LADD, CAROLYN LOUISE | 1622 | Final Rejection | Mar 10, 2022 |
| 17689117 | METHODS OF TREATING AND DIAGNOSING DISEASE USING BIOMARKERS FOR BCG THERAPY | The General Hospital Corporation | LYONS, MARY M | 1645 | Final Rejection | Mar 08, 2022 |
| 17637392 | COMPSTATIN ANALOGUES AND THEIR MEDICAL USES | Zp Spv 3 K/S | COFFA, SERGIO | 1658 | Non-Final OA | Feb 22, 2022 |
| 17586277 | DUAL ATM AND DNA-PK INHIBITORS FOR USE IN ANTI-TUMOR THERAPY | Xrad Holding Cayman Limited | MAHLUM, JONATHAN DAVIS | 1625 | Non-Final OA | Jan 27, 2022 |
| 17629918 | ADOPTIVE TRANSFER OF PLASMACYTOID DENDRITIC CELLS TO PREVENT OR TREAT HAIR LOSS | Tufts Medical Center, Inc. | MIANO, JOSEPH PAUL | 1631 | Final Rejection | Jan 25, 2022 |
| 17629313 | PEPTIDE HAVING HAIR GROWTH PROMOTING ACTIVITY, AND USE THEREOF | Caregen Co., Ltd. | NIEBAUER, RONALD T | 1658 | Final Rejection | Jan 21, 2022 |
| 17627966 | METHODS AND COMPOSITIONS FOR GENE SPECIFIC DEMETHYLATION AND ACTIVATION | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | GOMEZ RODRIGUEZ, JULIO WASHINGTON | 1637 | Final Rejection | Jan 18, 2022 |
| 17627854 | HOST-INDEPENDENT EXPRESSION OF BACTERIOPHAGES | Technische Universität München | WANG, RUIXUE | 1672 | Non-Final OA | Jan 18, 2022 |
| 17573730 | ANTI-CD40 ANTIBODIES AND USES THEREOF | Emory University | YU, MISOOK | 1641 | Non-Final OA | Jan 12, 2022 |
| 17597351 | METHODS FOR THE TREATMENT OF EPILEPSY | Centre National De La Recherche Scientifique | MEYERING, SHABANA SHABBEER | 1635 | Final Rejection | Jan 04, 2022 |
| 17596491 | TARGETING DNA REPAIR IN TUMOR CELLS VIA INHIBITION OF ERCC1-XPF | The Governors of the University of Alberta | MARTIN, KEVIN STEPHEN | 1624 | Non-Final OA | Dec 10, 2021 |
| 17617731 | MEMBRANE ATTACK COMPLEXES AND USES THEREOF | The Brigham And Women'S Hospital, Inc. | QIAN, CELINE X | 1637 | Final Rejection | Dec 09, 2021 |
| 17616144 | Kisspeptins to Predict and Treat Delayed Puberty | Children`S Medical Center Corporation | DABKOWSKI, ERINNE R | 1654 | Final Rejection | Dec 02, 2021 |
| 17615410 | TUMOR CELL-DERIVED EXOSOMES AND THEIR APPLICATIONS | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION | DENT, ALANA HARRIS | 1643 | Final Rejection | Nov 30, 2021 |
| 17610360 | COMPOSITIONS AND METHODS FOR HOMOLOGY DIRECTED REPAIR | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | REGA, KYLE THOMAS | 1636 | Final Rejection | Nov 10, 2021 |
| 17510981 | METHOD FOR OBTAINING IMMUNO-STIMULATORY DENDRITIC CELLS | Yale University | SCHUBERG, LAURA J | 1631 | Non-Final OA | Oct 26, 2021 |
| 17440081 | CARDIOMYOCYTE PROLIFERATION | The Queensland Institute of Medical Research | TRAN, KHOA NHAT | 1632 | Final Rejection | Sep 16, 2021 |
| 17405706 | PHOSPHONOACETATE GAPMER OLIGONUCLEOTIDES | Roche Innovation Center Copenhagen A/S | ZAHORIK, AMANDA MARY | 1636 | Final Rejection | Aug 18, 2021 |
| 17427453 | ANTIMICROBIAL ENDOLYSIN POLYPEPTIDES, COMPOSITIONS AND FORMULATIONS | Axitan Holdings, Inc. | HELLMAN, KRISTINA M | 1654 | Non-Final OA | Jul 30, 2021 |
| 17426433 | A PROCESS FOR PRODUCING SYNTHETIC JET FUEL | Greenfield Global Inc. | STEIN, MICHELLE | 1771 | Non-Final OA | Jul 28, 2021 |
| 17310235 | OLIGONUCLEOTIDES AND METHODS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION | The Schepens Eye Research Institute, Inc. | PYLA, EVELYN Y | 1633 | Final Rejection | Jul 27, 2021 |
| 17425058 | METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF OCULAR DISEASES AND CONDITIONS | Tufts Medical Center, Inc. | TRAN, CHRISTINA L | 1637 | Final Rejection | Jul 22, 2021 |
| 17424985 | B CELL IMMUNOTHERAPY | Holy Cross Hospital, Inc. | TICHY, JENNIFER M.H. | 1653 | Non-Final OA | Jul 22, 2021 |
| 17413223 | COMPOSITIONS AND METHODS FOR THE DELIVERY OF THERAPEUTIC AGENTS ACROSS THE ROUND WINDOW MEMBRANE | Decibel Therapeutics, Inc. | REYNOLDS, FRED H | 1658 | Non-Final OA | Jun 11, 2021 |
| 17297228 | SOLID STATE BATTERIES | President and Fellows of Harvard College | LU, ZIHENG NMN | 1752 | Non-Final OA | May 26, 2021 |
| 17292107 | PATIENT-DERIVED AMYLOID XENOGRAFT NON-HUMAN ANIMAL MODEL | Neurimmune AG | LEVIN, JOEL D | 1633 | Non-Final OA | May 07, 2021 |
| 17291192 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ESTROGEN-DEPENDENT DISORDERS | Obseva S.A. | WELLS, LAUREN QUINLAN | 1622 | Non-Final OA | May 04, 2021 |
| 17279691 | FORMULATIONS OF GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES | Zealand Pharma A/S | BEANE, RANDALL L | 1654 | Non-Final OA | Mar 25, 2021 |
| 17276252 | FORMULATIONS OF GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES | Zealand Pharma A/S | BEANE, RANDALL L | 1654 | Final Rejection | Mar 15, 2021 |
| 17257055 | COMPOSITIONS AND METHODS FOR REDUCTION OF LIPOPROTEIN A FORMATION AND TREATMENT OF AORTIC VALVE SCLEROSIS AND AORTIC STENOSIS | Abcentra, LLC | FONTAINHAS, AURORA M | 1675 | Final Rejection | Dec 30, 2020 |
| 17056368 | SPLICE MODULATING OLIGONUCLEOTIDES TARGETING RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS AND METHODS OF USE | Lifesplice Pharma LLC | JOHNSON, ALLISON MARIE | 1638 | Non-Final OA | Nov 17, 2020 |
| 16464383 | KETAMINE FOR THE TREATMENT OF MENSTRUALLY RELATED SYMPTOMS | Unknown | RODRIGUEZ, RAYNA B | 1628 | Final Rejection | May 28, 2019 |
| 16319849 | PEPTIDE-COATED CALCIUM PHOSPHATE PARTICLES | Cerapedics, Inc. | LEE, JIA-HAI | 1658 | Non-Final OA | Jan 23, 2019 |
| 16209279 | CONTAINER SYSTEM FOR RELEASABLY STORING A SUBSTANCE | Dna Genotek Inc. | LE, AUSTIN Q | 1796 | Non-Final OA | Dec 04, 2018 |
| 15771043 | NOVEL POLYPEPTIDES WITH IMPROVED PROTEOLYTIC STABILITY, AND METHODS OF PREPARING AND USING SAME | Tufts Medical Center, Inc. | REYNOLDS, FRED H | 1658 | Non-Final OA | Apr 25, 2018 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial